Fisher & Paykel Healthcare (NZE:FPH, ASX:FPH) provided revenue and net profit guidance of NZ$1.08 billion and NZ$200 million, respectively, for the first half of fiscal 2026, according to a Thursday filing with the New Zealand and Australian bourses.
The guidance indicates a 13% increase in reported operating revenue and a 31% growth in reported net profit after tax compared with the first half of fiscal 2025, the filing said.
The company's fiscal 2026 outlook remains unchanged, with operating revenue in the range of NZ$2.15 billion to NZ$2.25 billion and net profit of between NZ$390 million and NZ$440 million, per the filing.
Shares rose 1% in Australian morning trade and nearly 2% in NZ afternoon trade.